RSS   Newsletter   Contact   Advertise with us

Exosome names John Boyce as CEO

Share on Twitter Share on LinkedIn
Staff writer | Cambridge, Mass., USA | November 3, 2015
John BoyceExosome Diagnostics, a blood-based cancer molecular diagnostics company, has announced the appointment of John Boyce as its chief executive officer.
Most recently, Mr. Boyce was the CEO of GnuBIO, Inc., a desktop DNA sequencing company that he co-founded in January 2011.

GnuBIO was acquired by Bio-Rad in April 2014.

Prior to GnuBIO, Mr. Boyce started and sold Affomix, a digital proteomics company, to Illumina resulting in a significant return on investment for investors and shareholders within two years.

Through the course of his career, he served in key positions in numerous life sciences companies to drive them either towards an acquisition or an IPO.

Mr. Boyce also conceived, founded, and ran the Consumer Genetics Conference, which was acquired by Cambridge Healthtech Institute in 2012.

In 2013, he was awarded the honor as one of the top 15 technology luminaries in Massachusetts by the Boston Business Journal and Mass High Technology.

In 2014, Mr. Boyce was made a Fellow at Harvard University and co-teaches "Innovation in Science and Engineering” (ES-139).


 LATEST MOVES FROM Massachusetts 


MORE INSIDE POST